Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 621072, 9 pages
http://dx.doi.org/10.1155/2015/621072
Research Article

Macrophage Migration Inhibitory Factor Interacting with Th17 Cells May Be Involved in the Pathogenesis of Autoimmune Damage in Hashimoto’s Thyroiditis

1Department of Endocrinology and Metabolism, Binzhou Medical University Hospital, 661 Second Huanghe Road, Binzhou 256603, China
2Department of Endocrinology, Wudi County People’s Hospital, Tengda Street, Wudi 251900, China
3Department of Clinical Nutrition, Binzhou Medical University Hospital, 661 Second Huanghe Road, Binzhou 256603, China
4Department of Dermatology, Binzhou Medical University Hospital, 661 Second Huanghe Road, Binzhou 256603, China

Received 16 January 2015; Accepted 2 March 2015

Academic Editor: Amedeo Amedei

Copyright © 2015 Haibo Xue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. A. McLeod and D. S. Cooper, “The incidence and prevalence of thyroid autoimmunity,” Endocrine, vol. 42, no. 2, pp. 252–265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. P. J. Vanderpump, “The epidemiology of thyroid disease,” British Medical Bulletin, vol. 99, no. 1, pp. 39–51, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. H. Golden, K. A. Robinson, I. Saldanha, B. Anton, and P. W. Ladenson, “Prevalence and incidence of endocrine and metabolic disorders in the united states: a comprehensive review,” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 6, pp. 1853–1878, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Delemer, J.-P. Aubert, P. Nys, F. Landron, and S. Bouée, “An observational study of the initial management of hypothyroidism in France: The ORCHIDÉE study,” European Journal of Endocrinology, vol. 167, no. 6, pp. 817–823, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. E. N. Pearce, A. P. Farwell, and L. E. Braverman, “Thyroiditis,” The New England Journal of Medicine, vol. 348, no. 26, pp. 2646–2655, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Antonelli, S. M. Ferrari, A. Corrado et al., “Autoimmune thyroid disorders,” Autoimmunity Reviews, vol. 14, no. 2, pp. 174–180, 2015. View at Google Scholar
  7. W. Teng, Z. Shan, X. Teng et al., “Effect of iodine intake on thyroid diseases in China,” The New England Journal of Medicine, vol. 354, no. 26, pp. 2783–2793, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. B. R. Bloom and B. Bennett, “Mechanism of a reaction in vitro associated with delayed-type hypersensitivity,” Science, vol. 153, no. 3731, pp. 80–82, 1966. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Nishihira, “Molecular function of macrophage migration inhibitory factor and a novel therapy for inflammatory bowel disease,” Annals of the New York Academy of Sciences, vol. 1271, no. 1, pp. 53–57, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. N. Hoes, M. C. van der goes, J. W. G. Jacobs, F. P. G. J. Lafeber, J. W. J. Bijlsma, and J. A. G. van Roon, “Changes in macrophage inhibitory factor correlate with changes in bone mineral density in glucocorticoid-treated patients with rheumatoid arthritis,” Rheumatology, vol. 50, no. 10, Article ID ker268, pp. 1921–1924, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Ma, H.-B. Xue, X.-H. Guan et al., “Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris,” Brazilian Journal of Medical and Biological Research, vol. 46, no. 5, pp. 460–464, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. H. Liu, C. C. Chen, C. M. Yang, Y. J. Chen, and F. J. Tsai, “Dual effect of a polymorphism in the macrophage migration inhibitory factor gene is associated with new-onset graves disease in a Taiwanese Chinese population,” PLoS ONE, vol. 9, no. 3, Article ID e92849, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Bettelli, M. Oukka, and V. K. Kuchroo, “TH-17 cells in the circle of immunity and autoimmunity,” Nature Immunology, vol. 8, no. 4, pp. 345–350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Ouyang, J. K. Kolls, and Y. Zheng, “The biological functions of T helper 17 cell effector cytokines in inflammation,” Immunity, vol. 28, no. 4, pp. 454–467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Stojanović, T. Cvjetićanin, S. Lazaroski, S. Stošić-Grujičić, and D. Miljković, “Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells,” Immunology, vol. 126, no. 1, pp. 74–83, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Li, H.-Y. Mo, G. Xiong et al., “Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients,” The Journal of Biological Chemistry, vol. 287, no. 42, pp. 35484–35495, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Caturegli, A. de Remigis, and N. R. Rose, “Hashimoto thyroiditis: clinical and diagnostic criteria,” Autoimmunity Reviews, vol. 13, no. 4-5, pp. 391–397, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. J. T. Dunn, H. E. Crutchfield, and R. Gutekunst, Methods for Measuring Iodine in Urine, International Council for the Control of Deficiency Disorders, Wageningen, The Netherlands, 1993.
  20. T. Calandra, “Macrophage migration inhibitory factor and host innate immune responses to microbes,” Scandinavian Journal of Infectious Diseases, vol. 35, no. 9, pp. 573–576, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Roger, J. David, M. P. Glauser, and T. Calandra, “MIF regulates innate immune responses through modulation of Toll-like receptor 4,” Nature, vol. 414, no. 6866, pp. 920–924, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. G. M. Cox, A. P. Kithcart, D. Pitt et al., “Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation,” Journal of Immunology, vol. 191, no. 3, pp. 1043–1054, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Wang, X. Huang, P. J. Wolters et al., “Cutting edge: deficiency of macrophage migration inhibitory factor impairs murine airway allergic responses,” The Journal of Immunology, vol. 177, no. 9, pp. 5779–5784, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Nakamaru, N. Oridate, J. Nishihira, D. Takagi, Y. Furuta, and S. Fukuda, “Macrophage migration inhibitory factor (MIF) contributes to the development of allergic rhinitis,” Cytokine, vol. 31, no. 2, pp. 103–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Yoshihisa, T. Makino, K. Matsunaga et al., “Macrophage migration inhibitory factor is essential for eosinophil recruitment in allergen-induced skin inflammation,” Journal of Investigative Dermatology, vol. 131, no. 4, pp. 925–931, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. E. V. Acosta-Rodriguez, G. Napolitani, A. Lanzavecchia, and F. Sallusto, “Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells,” Nature Immunology, vol. 8, no. 9, pp. 942–949, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. N. J. Wilson, K. Boniface, J. R. Chan et al., “Development, cytokine profile and function of human interleukin 17-producing helper T cells,” Nature Immunology, vol. 8, no. 9, pp. 950–957, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. R. P. Singh, S. Hasan, S. Sharma et al., “Th17 cells in inflammation and autoimmunity,” Autoimmunity Reviews, vol. 13, no. 12, pp. 1174–1181, 2014. View at Google Scholar
  29. N. Figueroa-Vega, M. Alfonso-Pérez, I. Benedicto, F. Sánchez-Madrid, R. González-Amaro, and M. Marazuela, “Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 2, pp. 953–962, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Peng, B. Xu, Y. Wang, H. Guo, and Y. Jiang, “A high frequency of circulating Th22 and Th17 cells in patients with new onset Graves’ disease,” PLoS ONE, vol. 8, no. 7, Article ID e68446, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Caturegli, A. de Remigis, K. Chuang, M. Dembele, A. Iwama, and S. Iwama, “Hashimoto's thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records,” Thyroid, vol. 23, no. 2, pp. 142–150, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Carlé, P. Laurberg, N. Knudsen et al., “Thyroid peroxidase and thyroglobulin auto-antibodies in patients with newly diagnosed overt hypothyroidism,” Autoimmunity, vol. 39, no. 6, pp. 497–503, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. S. M. McLachlan and B. Rapoport, “Thyroid peroxidase as an autoantigen,” Thyroid, vol. 17, no. 10, pp. 939–948, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. A. A. Pandit, M. V. Warde, and P. S. Menon, “Correlation of number of intrathyroid lymphocytes with antimicrosomal antibody titer in Hashimoto's thyroiditis,” Diagnostic Cytopathology, vol. 28, no. 2, pp. 63–65, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Bacher, C. N. Metz, T. Calandra et al., “An essential regulatory role for macrophage migration inhibitory factor in T-cell activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 15, pp. 7849–7854, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Yang, M. S. Sundrud, J. Skepner, and T. Yamagata, “Targeting Th17 cells in autoimmune diseases,” Trends in Pharmacological Sciences, vol. 35, no. 10, pp. 493–500, 2014. View at Publisher · View at Google Scholar